The global overactive bladder treatment market size is estimated at 1,596.19 Million USD with a CAGR of 4.8% during the forecasted period from 2021-2028.
Table of Content 1 Overactive Bladder Treatment Market Overview 1.1 Product Overview and Scope of Overactive Bladder Treatment 1.2 Classification of Overactive Bladder Treatment by Type 1.2.1 Global Overactive Bladder Treatment Market Revenue Comparison by Type (2019-2026) 1.2.2 Global Overactive Bladder Treatment Revenue Market Share by Type in 2018 1.2.3 Anticholinergics 1.2.4 Mirabegron 1.2.5 Botox 1.2.6 Others 1.3 Global Overactive Bladder Treatment Market by Application 1.3.1 Global Overactive Bladder Treatment Market Size and Market Share Comparison by Applications (2019-2026) 1.3.2 Idiopathic Bladder Overactivity 1.3.3 Neurogenic Bladder Overactivity 1.4 Global Overactive Bladder Treatment Market by Regions 1.4.1 Global Overactive Bladder Treatment Market Size (Million USD) Comparison by Regions (2019-2026) 1.4.2 North America (USA, Canada, and Mexico) Overactive Bladder Treatment Status and Prospect (2014-2026) 1.4.3 Europe (Germany, France, UK, Russia, and Italy) Overactive Bladder Treatment Status and Prospect (2014-2026) 1.4.4 Asia-Pacific (China, Japan, Korea, India, and Southeast Asia) Overactive Bladder Treatment Status and Prospect (2014-2026) 1.4.5 South America (Brazil, Argentina, Colombia) Overactive Bladder Treatment Status and Prospect (2014-2026) 1.4.6 The Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa) Overactive Bladder Treatment Status and Prospect (2014-2026) 1.5 Global Market Size of Overactive Bladder Treatment (2014-2026) 2 Company Profiles 2.1 Astellas Pharma Inc. 2.1.1 Company Basic Information and Its Competitors 2.1.2 Astellas Pharma Inc. Product Category 2.1.2.1 MYRBETRIQ (mirabegron) 2.1.3 Astellas Pharma Inc. Overactive Bladder Treatment Revenue (2017-2018) 2.1.4 Astellas Pharma Inc. Recent Developments 2.1.5 Main Business/Business Overview 2.2 Pfizer, Inc. 2.2.1 Company Basic Information and Its Competitors 2.2.2 Pfizer, Inc. Product Category 2.2.2.1 TOVIAZ 2.2.3 Pfizer, Inc. Overactive Bladder Treatment Revenue (2017-2018) 2.2.4 Main Business/Business Overview 2.3 Teva Pharmaceutical Industries Limited 2.3.1 Company Basic Information and Its Competitors 2.3.2 Teva Pharmaceutical Industries Limited Product Category 2.3.2.1 VESIcare (solifenacin succinate) 2.3.3 Teva Pharmaceutical Industries Limited Overactive Bladder Treatment Revenue (2017-2018) 2.3.4 Teva Pharmaceutical Industries Limited Recent Developments 2.3.5 Main Business/Business Overview 2.4 Allergan plc 2.4.1 Company Basic Information and Its Competitors 2.4.2 Allergan plc Product Category 2.4.2.1 BOTOX (onabotulinumtoxinA) 2.4.3 Allergan plc Overactive Bladder Treatment Revenue (2017-2018) 2.4.4 Allergan plc Recent Developments 2.4.5 Main Business/Business Overview 2.5 Mylan N.V. 2.5.1 Company Basic Information and Its Competitors 2.5.2 Mylan N.V. Product Category 2.5.2.1 TOLTERODINE TARTRATE 2.5.3 Mylan N.V. Overactive Bladder Treatment Revenue (2017-2018) 2.5.4 Main Business/Business Overview 2.6 Endo International Plc 2.6.1 Company Basic Information and Its Competitors 2.6.2 Endo International Plc Product Category 2.6.2.1 Oxybutynin Chloride 10% Gel 2.6.3 Endo International Plc Overactive Bladder Treatment Revenue (2017-2018) 2.6.4 Main Business/Business Overview 2.7 Hisamitsu Pharmaceutical Co., Inc. 2.7.1 Company Basic Information and Its Competitors 2.7.2 Hisamitsu Pharmaceutical Co., Inc. Product Category 2.7.2.1 NEOXY Tape 2.7.2.2 OABLOK PATCH 2.7.3 Hisamitsu Pharmaceutical Co., Inc. Overactive Bladder Treatment Revenue (2017-2018) 2.7.4 Hisamitsu Pharmaceutical Co., Inc. Recent Developments 2.7.5 Main Business/Business Overview 2.8 Sanofi 2.8.1 Company Basic Information and Its Competitors 2.8.2 Sanofi Product Category 2.8.2.1 Ditropan 2.8.3 Sanofi Overactive Bladder Treatment Revenue (2017-2018) 2.8.4 Main Business/Business Overview 2.9 Aurobindo Pharma Limited 2.9.1 Company Basic Information and Its Competitors 2.9.2 Aurobindo Pharma Limited Product Category 2.9.2.1 solifenacin succinate 2.9.3 Aurobindo Pharma Limited Overactive Bladder Treatment Revenue (2017-2018) 2.9.4 Main Business/Business Overview 2.1 Janssen Pharmaceuticals Inc 2.10.1 Company Basic Information and Its Competitors 2.10.2 Janssen Pharmaceuticals Inc Product Category 2.10.2.1 DITROPAN XL 2.10.3 Janssen Pharmaceuticals Inc Overactive Bladder Treatment Revenue (2017-2018) 2.10.4 Main Business/Business Overview 3 Global Overactive Bladder Treatment Market Competition, by Players 3.1 Global Overactive Bladder Treatment Market Revenue and Share by Players (2017-2018) 3.2 Market Concentration Rate 3.2.1 Top 3 Overactive Bladder Treatment Players Market Share 3.2.2 Top 5 Overactive Bladder Treatment Players Market Share 4 Global Overactive Bladder Treatment Market Size by Regions 4.1 Global Overactive Bladder Treatment Market Revenue, and Market Share by Regions 4.2 North America Overactive Bladder Treatment Market Revenue, and Growth Rate (2014-2019) 4.3 Europe Overactive Bladder Treatment Market Revenue, and Growth Rate (2014-2019) 4.4 Asia-Pacific Overactive Bladder Treatment Market Revenue, and Growth Rate (2014-2019) 4.5 South America Overactive Bladder Treatment Market Revenue, and Growth Rate (2014-2019) 4.6 the Middle East & Africa Overactive Bladder Treatment Market Revenue, and Growth Rate (2014-2019) 5 North America Overactive Bladder Treatment Market Revenue by Countries 5.1 North America Overactive Bladder Treatment Market Revenue, By Countries (2014-2019) 5.2 USA Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 5.3 Canada Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 5.4 Mexico Overactive Bladder Treatment Revenue and Growth Rate (2014-2019) 6 Europe Overactive Bladder Treatment Market Revenue by Countries 6.1 Europe Overactive Bladder Treatment Market Revenue, By Countries (2014-2019) 6.2 Germany Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 6.3 France Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 6.4 UK Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 6.5 Italy Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 6.6 Russia Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Overactive Bladder Treatment Revenue by Countries 7.1 Asia-Pacific Overactive Bladder Treatment Market Revenue, By Countries (2014-2019) 7.2 China Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 7.3 Japan Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 7.4 Korea Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 7.5 India Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 8 South America Overactive Bladder Treatment Revenue by Countries 8.1 South America Overactive Bladder Treatment Market Revenue, By Countries (2014-2019) 8.2 Brazil Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 8.3 Argentina Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 9 The Middle East & Africa Revenue Overactive Bladder Treatment by Countries 9.1 The Middle East & Africa Overactive Bladder Treatment Market Revenue by Countries (2014-2019) 9.2 Saudi Arabia Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 9.3 UAE Overactive Bladder Treatment Revenue and Growth Rate (2014-2019) 9.4 Egypt Overactive Bladder Treatment Market Revenue and Growth Rate (2014-2019) 9.5 South Africa Overactive Bladder Treatment Revenue and Growth Rate (2014-2019) 10 Global Overactive Bladder Treatment Market Segment by Type 10.1 Global Overactive Bladder Treatment Market Revenue and Market Share by Type (2014-2019) 10.2 Global Overactive Bladder Treatment Market Forecast by Type (2019-2026) 10.3 Anticholinergics, Overactive Bladder Treatment Market Revenue (2014-2026) 10.4 Mirabegron, Overactive Bladder Treatment Market Revenue (2014-2026) 10.5 Botox, Overactive Bladder Treatment Market Revenue (2014-2026) 10.6 Others, Overactive Bladder Treatment Market Revenue (2014-2026) 11 Global Overactive Bladder Treatment Market Segment by Application 11.1 Global Overactive Bladder Treatment Market Share by Application (2014-2019) 11.2 Overactive Bladder Treatment Market Forecast by Application (2019-2026) 11.3 Idiopathic Bladder Overactivity Revenue (2014-2026) 11.4 Neurogenic Bladder Overactivity Revenue (2014-2026) 12 Global Overactive Bladder Treatment Market Size Forecast (2019-2026) 12.1 Global Overactive Bladder Treatment Market Size Forecast (2019-2026) 12.2 Global Overactive Bladder Treatment Market Revenue Forecast by Regions (2019-2026) 12.3 North America Overactive Bladder Treatment Revenue Market Forecast (2019-2026) 12.4 Europe Overactive Bladder Treatment Revenue Market Forecast (2019-2026) 12.5 Asia-Pacific Overactive Bladder Treatment Revenue Market Forecast (2019-2026) 12.6 South America Overactive Bladder Treatment Revenue Market Forecast (2019-2026) 12.7 The Middle East & Africa Overactive Bladder Treatment Revenue Market Forecast (2019-2026) 13 Appendix 13.1 Methodology 13.2 Primary Research 13.3 Research Methodology 13.4 Assumptions & Exclusions 13.5 Secondary data sources 13.6 Disclaimer